SCC
CRL icon

Spring Creek Capital’s Charles River Laboratories CRL Stock Holding History

Spring Creek Capital’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10,612
Closed -$1.19M – 186
2018
Q2 		$1.19M Buy
+10,612
New +$1.15M 0.14% 91

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Spring Creek Capital's CRL Position: Q3 2018 in Review

Spring Creek Capital sold out of Charles River Laboratories (CRL) in Q3 2018, closing a stake of 10,612 shares — an estimated $1.19M sold.

Spring Creek Capital first reported a position in CRL in Q2 2018 and held it in 1 quarter. The position peaked at $1.19M in Q2 2018. 366 funds tracked by Wall St. Rank hold CRL as of Q3 2018.

  • Spring Creek Capital reported no remaining Charles River Laboratories position as of Q3 2018 after selling out during the quarter.
  • Spring Creek Capital sold 10,612 Charles River Laboratories shares in Q3 2018, an estimated $1.19M.
  • Spring Creek Capital first reported a position in Charles River Laboratories in Q2 2018 and held it in 1 quarter.
  • Spring Creek Capital's Charles River Laboratories position peaked at $1.19M in Q2 2018.
  • 366 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2018.

Based on Spring Creek Capital's 13F filing for Q3 2018, filed 13 Nov 2018.